Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients With Non-alcoholic Steatohepatitis
Active, not recruiting
Tanta University
Phase 2
2021-09-01
This study aims at evaluating and comparing the protective outcomes of using Obeticholic acid
versus Vitamin E in NASH patients without cirrhosis. The intervention is 6-months duration
and the study will assess the efficacy of either drug as fibrosis improvement (≥ 1 stage)
with no worsening of NASH or NASH resolution with no worsening of fibrosis with the study
considered successful if either 1ry end point is met. . Also, assessment of biochemical
markers related to steatosis, inflammation, oxidative stress, insulin resistance and liver
fibrosis will be done.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
